SCHEMBL8332629

SCHEMBL8332629

COc1ccc(C(OCC(O)c2ccccc2[N+](=O)[O-])(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ NPC1 O15118 5/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ MAPT P10636 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ NPY1R P25929 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPY2R P49146 1/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PTPN1 P18031 1/20 0.38
▸ KIF11 P52732 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29451221 0.82 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL9098372 0.80 ALDH1A1 (0.47) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL8072121 0.78 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL9098377 0.77 MAOB (0.47) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL4948735 0.77 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL5700649 0.76 ALDH1A1 (0.42) SMN1; SMN2NPC1RAB9AKMT2AALDH1A1
SCHEMBL24937040 0.75 LMNA (0.46) KMT2ALMNAKIF11
SCHEMBL10434128 0.75 LMNA (0.46) KMT2ALMNAKIF11
SCHEMBL10434091 0.75 LMNA (0.46) KMT2ALMNAKIF11
SCHEMBL25713808 0.74 KIF11 (0.51) SMN1; SMN2KMT2AALDH1A1GAAKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5919917-A WITH NUCLEOTIDE SEQUENCE CAPABLE OF HYBRIDIZATION TO TARGET NUCLEIC ACID AFTER DECYCLIZATION; EXONUCLEASE AND ENDONUCLEASE RESISTANT; FOR ANTISENSE GENE THERAPY LABORATORY OF MOLECULAR BIOPHOTONICS (JP) 1999-07-06 — — US disclosed
EP-0543889-B1 INCORPORATION OF SELECTABLY CLEVABLE SITES INTO OLIGONUCLEOTIDE CHAINS AND REAGENTS THEREFOR CHIRON CORP (US) 1999-04-21 — — EP disclosed
EP-0900805-A2 Incorporation of selectably cleavable and/or abasic sites into oligonucleotide chains and reagents therefor CHIRON CORPORATION (US) 1999-03-10 — — EP disclosed
EP-0855403-A1 PHOTOCLEAVABLE CYCLIC OLIGONUCLEOTIDE Laboratory of Molecular Biophotonics (JP) 1998-07-29 — — EP disclosed
US-5578717-A Nucleotides for introducing selectably cleavable and/or abasic sites into oligonucleotides CHIRON CORPORATION (US) 1996-11-26 — — US disclosed
US-5545730-A Multifunctional nucleic acid monomer CHIRON CORPORATION (US) 1996-08-13 — — US disclosed
US-5430136-A Oligonucleotides having selectably cleavable and/or abasic sites CHIRON CORPORATION (US) 1995-07-04 — — US disclosed
US-5367066-A Oligonucleotides with selectably cleavable and/or abasic sites CHIRON CORPORATION (US) 1994-11-22 — — US disclosed
US-5258506-A Photolabile reagents for incorporation into oligonucleotide chains CHIRON CORPORATION (US) 1993-11-02 — — US disclosed
Send feedback